| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloid leukemia: highlights from ASH 2015
|
Pfeilstöcker, Michael
|
|
2016
|
9 |
3 |
p. 116-119
|
artikel
|
| 2 |
Antiangiogenic therapies in ovarian cancer
|
Reinthaller, Alexander
|
|
2016
|
9 |
3 |
p. 139-143
|
artikel
|
| 3 |
ASH 2015—insights and outlooks - ASH 2015 – Einblicke und Aussichten
|
Zojer, Niklas
|
|
2016
|
9 |
3 |
p. 107-108
|
artikel
|
| 4 |
ASH 2015 – stem cell transplantation
|
Clausen, Johannes
|
|
2016
|
9 |
3 |
p. 136-138
|
artikel
|
| 5 |
A welcome statement from the associate Editor-in-Chief
|
Bartsch, Rupert
|
|
2016
|
9 |
3 |
p. 106
|
artikel
|
| 6 |
Focus on multiple myeloma at ASH 2015
|
Zojer, Niklas
|
|
2016
|
9 |
3 |
p. 127-130
|
artikel
|
| 7 |
Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia
|
Mihaylov, Georgi
|
|
2016
|
9 |
3 |
p. 144-152
|
artikel
|
| 8 |
Indolent lymphoma at ASH 2015: new treatment approaches
|
Nösslinger, Thomas
|
|
2016
|
9 |
3 |
p. 120-123
|
artikel
|
| 9 |
Novel strategies in the management of chronic lymphocytic leukemia (CLL)
|
Heintel, Daniel
|
|
2016
|
9 |
3 |
p. 111-115
|
artikel
|
| 10 |
Practice changing information in aggressive lymphoma, ASH 2015
|
Fridrik, Michael A.
|
|
2016
|
9 |
3 |
p. 124-126
|
artikel
|
| 11 |
Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma
|
Hilbe, Wolfgang
|
|
2016
|
9 |
3 |
p. 109-110
|
artikel
|
| 12 |
Reversal of direct oral anticoagulants in hemophilia treatment
|
Feistritzer, Clemens
|
|
2016
|
9 |
3 |
p. 131-135
|
artikel
|
| 13 |
Welcome to the new associate Editor-in-Chief of memo
|
Hilbe, Wolfgang
|
|
2016
|
9 |
3 |
p. 105
|
artikel
|
Tijdschrift beschrijving